ife expectancy, advances in medicine, and the growing number of people living with chronic or complex illnesses. In many situations, the use of multiple medicines may be necessary and appropriate to improve quality of life, control symptoms, reduce complications, and support ongoing health management.

​

Polytherapy may sometimes improve treatment outcomes because different medicines can work through different mechanisms within the body. For example, in epilepsy, combining anti-seizure medicines may help achieve better seizure control when one medicine alone has not been effective.

​

Similarly, appropriate polypharmacy may allow several coexisting conditions to be treated safely and effectively simultaneously. Medicines may be prescribed to manage pain, blood pressure, hormonal conditions, mental health problems, neurological disorders, digestive issues, or metabolic disease simultaneously.

​

However, as the number of medicines increases, so does the complexity of treatment and the potential for harm. Medicines can interact with one another in unpredictable ways, affecting how they are absorbed, processed, or eliminated from the body. This can increase the risk of side effects, adverse effects, toxicity, prescribing errors, and adverse events.

​

One important concern associated with polypharmacy is the prescribing cascade. This occurs when side effects or adverse effects caused by one medicine are mistaken for a new medical condition, leading to additional medicines being prescribed to treat the new symptoms. Over time, this can result in an increasing number of medicines being added without recognising that the original cause may be medication-related. Prescribing cascades can increase treatment burden, worsen side effects, and raise the risk of further complications, interactions, and hospital admissions.

​

Individuals taking multiple medicines may experience fatigue, dizziness, sedation, memory difficulties, confusion, falls, sleep disturbances, gastrointestinal problems, hormonal disruption, cognitive impairment, nutritional deficiencies, or worsening physical and mental health. In some cases, symptoms may develop gradually and become difficult to separate from the underlying illness itself.

​

The risks associated with complex prescribing are recognised within healthcare safety research. A 2012 study commissioned by the General Medical Council and conducted in general practice examined the prevalence and nature of prescribing errors. The study found that approximately 1 in 20 prescription items contained an error, and around 1 in 550 prescription items had the potential to cause serious harm.

​

Further concerns regarding prescribing safety were also identified in the study Cross-sectional study of prescribing errors in patients admitted to nine hospitals across North West England, published in BMJ Open. The research highlighted how prescribing errors can occur across healthcare settings and reinforced the importance of improving medication safety systems, particularly for patients with complex treatment regimens and multiple medicines.

Because of these risks, regular medicine reviews, careful monitoring, clear communication, and shared decision-making are essential. Patients and families are often the first to recognise changes in symptoms or unexpected reactions, making their observations an important part of medicine safety and ongoing care.